GLP-1/GIP+B12, is our advanced compounded medication, carefully designed to combine the benefits of GLP-1/GIP with additional supportive ingredients. Tailored for individual patient needs, this customized formulation offers a personalized therapeutic option for those who may not tolerate standard formulations or require specialized care.

GLP-1/GIP+B12, plays a crucial role in regulating blood sugar, suppressing appetite, and promoting fat loss. The added supportive ingredients are selected to address common challenges associated with weight loss and diabetes treatment, such as fatigue, muscle loss, or neuropathy. These enhancements may help improve metabolic function, neurological health, and musculoskeletal strength, supporting overall wellness throughout the treatment process.

Compounded in strict compliance with Section 503A of the Federal Food, Drug, and Cosmetic Act, GLP-1/GIP+B12, is available only with a valid, patient-specific prescription from a licensed healthcare provider. This compounded medication is not affiliated with or endorsed by Eli Lilly and is not intended as a substitute for FDA-approved products. It is exclusively prepared for patients with clinical needs that cannot be met by commercially available alternatives and is not for resale, bulk distribution, or office use.

GLP-1/GIP+B12 is typically administered through a once-weekly injection, making it a convenient option for weight loss and diabetes management. Our healthcare providers will guide you through the process to ensure ease and comfort.

Many individuals start to notice significant weight loss within a few weeks to a few months of starting GLP-1/GIP+B12. Results can vary based on factors like diet, exercise, and individual response, with most seeing gradual progress over time.